A Review of Marine Algae as a Sustainable Source of Antiviral and Anticancer Compounds

Biopolymers, such as polysaccharides, polyphenols, alkaloids, and terpenoids, found in marine algae exhibit antiviral and anticancer properties. These compounds can inhibit viral replication, induce apoptosis in cancer cells, and enhance the immune response. Their diverse bioactive properties make marine algae a promising source for the development of sustainable antiviral and anticancer therapies. A major advantage of marine algae is that they do not require freshwater or arable land and can be cultivated in seawater, thus making them sustainable substitutes for conventional resources. Additionally, their ability to sequester carbon and recycle nutrients enhances their environmental sustainability. Despite their promising biomedical potential, challenges, such as compound extraction, large-scale production, and clinical validation, must be addressed for effective drug development. The vast biological diversity of marine algae across different ocean ecosystems is a largely unexplored source of distinct chemical structures, which may be the basis for new therapeutic schemes. Despite their therapeutic potential, the translation of marine algae-derived compounds into clinical applications faces significant hurdles, including challenges in large-scale extraction, bioavailability enhancement, and regulatory approval. The need to extract particular compounds to make them available for large-scale production and to overcome issues such as bioavailability and regulatory policies are formidable challenges. Marine algae represent innovative advances in antiviral and anticancer drug development, but only when combined with ecologically sound cultivation methods, interdisciplinary approaches, and understanding. The integration of advanced biotechnological approaches, innovative gene editing techniques, and environmentally sustainable aquaculture practices is pivotal for harnessing the full potential of marine algae for the development of next-generation antiviral and anticancer therapeutics.